Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 9;13(1):19.
doi: 10.1186/s13089-021-00223-9.

One-month outcomes of patients with SARS-CoV-2 infection and their relationships with lung ultrasound signs

Affiliations

One-month outcomes of patients with SARS-CoV-2 infection and their relationships with lung ultrasound signs

Thiago Thomaz Mafort et al. Ultrasound J. .

Abstract

Background: The role of lung ultrasound (LUS) in evaluating the mid- and long-term prognoses of patients with COVID-19 pneumonia is not yet known. The objectives of this study were to evaluate associations between LUS signs at the time of screening and clinical outcomes 1 month after LUS and to assess LUS signs at the time of presentation with known risk factors for COVID-19 pneumonia.

Methods: This was a retrospective study of data prospectively collected 1 month after LUS screening of 447 adult patients diagnosed with COVID-19 pneumonia. Sonographic examination was performed in screening tents with the participants seated. The LUS signs (B-lines > 2, coalescent B-lines, and subpleural consolidations) were captured in six areas of each hemithorax and a LUS aeration score was calculated; in addition, the categories of disease probability based on patterns of LUS findings (high-probability, intermediate-probability, alternate, and low-probability patterns) were evaluated. The LUS signs at patients' initial evaluation were related to the following outcomes: symptomatology, the need for hospitalization or invasive mechanical ventilation (IMV), and COVID-19-related death.

Results: According to the evaluations performed 1 month after LUS screening, 36 patients were hospitalised, eight of whom required intensive care unit (ICU) admission and three of whom died. The presence of coalescent B-lines was associated with the need for hospitalization (p = 0.008). The presence of subpleural consolidations was associated with dyspnoea (p < 0.0001), cough (p = 0.003), the need for hospitalization (p < 0.0001), the need for ICU admission (p < 0.0001), and death (p = 0.002). A higher aeration score was associated with dyspnoea (p < 0.0001), the need for hospitalization (p < 0.0001), the need for ICU admission (p < 0.0001), and death (p = 0.003). In addition, patients with a high-probability LUS pattern had a higher aeration score (p < 0.0001) and more dyspnoea (p = 0.024) and more often required hospitalization (p < 0.0001) and ICU admission (p = 0.031).

Conclusions: In patients with COVID-19 pneumonia, LUS signs were related to respiratory symptoms 1 month after LUS screening. Strong relationships were identified between LUS signs and the need for hospitalization and death.

Keywords: 1-month outcomes; COVID-19; Lung ultrasound; Pneumonia; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Representation of the 12 zones on the chest. a The anterior and axillary zones; b the posterior zones. The zones 1 and 2 are limited by the parasternal and anterior axillary lines. The zones 3 and 4 are limited by the anterior axillary and posterior axillary lines. Finally, the zones 5 and 6 are limited by the paravertebral and posterior axillary lines and by the contour of the scapula
Fig. 2
Fig. 2
Relationships between the presence of subpleural consolidation on lung ultrasound and the outcomes of a hospitalization (p < 0.0001) and b death (p = 0.002)
Fig. 3
Fig. 3
Relationships between the aeration score on lung ultrasound and the outcomes of a hospitalization (p < 0.0001) and b death (p = 0.003)

Similar articles

Cited by

References

    1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed
    1. Allinovi M, Parise A, Giacalone M, et al. Lung ultrasound may support diagnosis and monitoring of COVID-19 pneumonia. Ultrasound Med Biol. 2020;46:2908–2917. doi: 10.1016/j.ultrasmedbio.2020.07.018. - DOI - PMC - PubMed
    1. George PM, Barratt SL, Condliffe R, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75:1009–1016. doi: 10.1136/thoraxjnl-2020-215314. - DOI - PubMed
    1. Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55:2001217. doi: 10.1183/13993003.01217-2020. - DOI - PMC - PubMed
    1. Smargiassi A, Soldati G, Torri E, et al. Lung ultrasound for COVID-19 patchy pneumonia. J Ultrasound Med. 2021;40:521–528. doi: 10.1002/jum.15428. - DOI - PubMed

LinkOut - more resources